Targeting Peroxiredoxin 1 Impairs Growth of Breast Cancer Cells and Potently Sensitises These Cells to Prooxidant Agents

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0263-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

miR-1 Inhibits the Proliferation of Breast Cancer Stem Cells by Targeting EVI-1

OncoTargets and Therapy
OncologyPharmacology
2018English

A Novel Γ-Lactam-Based Histone Deacetylase Inhibitor Potently Inhibits the Growth of Human Breast and Renal Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

Repression of the Autophagic Response Sensitises Lung Cancer Cells to Radiation and Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2016English

Deficiency of CCN5/WISP-2-Driven Program in Breast Cancer Promotes Cancer Epithelial Cells to Mesenchymal Stem Cells and Breast Cancer Growth

Scientific Reports
Multidisciplinary
2017English

Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2017English

HER2 Signaling Pathway Activation and Response of Breast Cancer Cells to HER2-targeting Agents Is Dependent Strongly on the 3D Microenvironment

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

MicroRNA-20b Promotes Cell Growth of Breast Cancer Cells Partly via Targeting Phosphatase and Tensin Homologue (PTEN)

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2014English

Identifying and Targeting Tumor-Initiating Cells in the Treatment of Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy